That's a good point, but if you look at RedChip's valuations of PAA's assets you wouldn't call them extravagant, especially when you look at their list of comparable companies.
Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharm, page-14
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $50.92K | 290.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 152309 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 329859 | 3 |
View Market Depth
| Last trade - 15.48pm 11/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |